Spire Healthcare Group PLC (LON:SPI) shares hit a new 52-week low during trading on Wednesday . The company traded as low as GBX 218.20 ($3.01) and last traded at GBX 219.20 ($3.03), with a volume of 990964 shares traded. The stock had previously closed at GBX 224 ($3.09).

A number of research analysts have commented on the company. Liberum Capital boosted their price objective on Spire Healthcare Group from GBX 270 ($3.73) to GBX 275 ($3.80) and gave the stock a “hold” rating in a research note on Friday, January 26th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a GBX 339 ($4.68) price target on shares of Spire Healthcare Group in a research note on Thursday, January 4th. Numis Securities reiterated an “add” rating and issued a GBX 341 ($4.71) price target on shares of Spire Healthcare Group in a research note on Monday, October 23rd. Barclays started coverage on Spire Healthcare Group in a research note on Friday, February 2nd. They issued an “equal weight” rating and a GBX 270 ($3.73) price target on the stock. Finally, Jefferies Group upgraded Spire Healthcare Group to a “buy” rating and boosted their price target for the stock from GBX 259 ($3.58) to GBX 290 ($4.01) in a research note on Wednesday, January 17th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company’s stock. Spire Healthcare Group currently has an average rating of “Hold” and an average price target of GBX 304.29 ($4.20).

The stock has a market cap of $885.59 and a P/E ratio of 3,131.43.

In other news, insider Justin Ash acquired 84,500 shares of the stock in a transaction that occurred on Thursday, November 23rd. The stock was purchased at an average cost of GBX 237 ($3.27) per share, with a total value of £200,265 ($276,685.55). Also, insider Peter R. Bamford acquired 5,000 shares of the stock in a transaction that occurred on Monday, November 27th. The stock was purchased at an average cost of GBX 240 ($3.32) per share, with a total value of £12,000 ($16,579.17).

TRADEMARK VIOLATION WARNING: This report was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://theolympiareport.com/2018/02/14/spire-healthcare-group-spi-sets-new-52-week-low-at-218-20.html.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.